
Eyebot is a technology company focused on revolutionizing vision care by providing fast, accessible, and automated 90-second vision tests and eyewear prescriptions through AI-powered kiosks. Their solutions eliminate traditional barriers such as scheduling and limited doctor availability, enabling customers to get prescriptions instantly and shop for glasses conveniently. Eyebot partners with leading optical brands like Zenni to deliver high-throughput vision testing in retail and everyday locations, significantly increasing engagement and optical sales. The company addresses the growing demand for vision care amid a shortage of eye doctors, aiming to make vision care accessible to everyone with an outcome-focused, mission-driven approach.

Eyebot is a technology company focused on revolutionizing vision care by providing fast, accessible, and automated 90-second vision tests and eyewear prescriptions through AI-powered kiosks. Their solutions eliminate traditional barriers such as scheduling and limited doctor availability, enabling customers to get prescriptions instantly and shop for glasses conveniently. Eyebot partners with leading optical brands like Zenni to deliver high-throughput vision testing in retail and everyday locations, significantly increasing engagement and optical sales. The company addresses the growing demand for vision care amid a shortage of eye doctors, aiming to make vision care accessible to everyone with an outcome-focused, mission-driven approach.
What they do: AI/computer-vision kiosks that deliver ~90-second vision tests and generate eyeglass prescriptions
Headquarters & founding: Boston; founded 2021
Founders: Matthias Hofmann (Co‑Founder & CEO) and Jack Moldave (Co‑Founder & CTO)
Funding to date: Reported seed and Series A rounds; reported total > $30M by Aug 2025
Access to vision care and scalable prescription delivery amid clinician shortages.
2021
Health tech / Vision care
6000000.00
Seed round reported with participation from additional VC firms
20000000.00
Round reported to bring total funding to more than $30M
“Includes venture investors (AlleyCorp, Ubiquity Ventures, General Catalyst) and participation from multiple VC firms; grant support reported from MassVentures and the National Science Foundation”